TrueMark Investments, LLC GSK — GSK PLC

Ownership history in TrueMark Investments, LLC  ·  5 quarters on record

AI Ownership Summary

TrueMark Investments, LLC reported GSK PLC (GSK) in 5 quarterly 13F filings from 2025 Q1 through 2026 Q1. Peak portfolio weight reached 1.24% in 2026 Q1. The latest visible filing shows GSK at 1.24% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this GSK ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was TrueMark Investments, LLC's position in GSK PLC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

GSK was reported at 1.24% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.24% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

GSK stock page TrueMark Investments, LLC fund profile TrueMark Investments, LLC full holdings
How TrueMark Investments, LLC held GSK — position size vs. price
% of Fund (quarterly)    GSK price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 115,322 +14,190 +14.0% 1.24% $6.4M 2026-04-20 $56.83
2025 Q4 ADDED — — — 101,132 +13,158 +15.0% 0.95% $5.0M 2026-01-14 $49.93
2025 Q3 ADDED — — — 87,974 +4,832 +5.8% 0.66% $3.8M 2025-10-30 $45.74
2025 Q2 ADDED — — — 83,142 +12,880 +18.3% 0.69% $3.2M 2025-07-29 $36.31
2025 Q1 INITIATED — — — 70,262 — — 0.71% $2.7M 2025-04-22 $34.90

🏢 Other funds also holding GSK

As of 2026 Q2 — sorted by position size

Keystone Financial Planning, Inc. 3Y 7Y 2.64% KEATING INVESTMENT COUNSELORS INC 3Y 7Y 2.4% Gilman Hill Asset Management, LLC 3Y 7Y 0.92% Yoffe Investment Management, LLC 0.82% Stablepoint Partners, LLC 0.8% TOWER TRUST & INVESTMENT Co 0.73% BONNESS ENTERPRISES INC 3Y 7Y 0.7% Douglas Lane & Associates, LLC 3Y 7Y 0.67% InvesTrust 0.58% ARS Wealth Advisors Group, LLC 3Y 0.52%

FAQ About TrueMark Investments, LLC and GSK

These are the practical questions this page is built to answer before you even open the full history table.

How long has TrueMark Investments, LLC reported owning GSK?

TrueMark Investments, LLC reported GSK across 5 quarterly 13F filings, from 2025 Q1 through 2026 Q1.

What was the largest reported GSK position in TrueMark Investments, LLC's portfolio?

The largest reported portfolio weight for GSK was 1.24% in 2026 Q1.

What is the latest reported GSK position on this page?

The most recent filing on this page is 2026 Q1, when TrueMark Investments, LLC reported 115,322 shares, equal to 1.24% of portfolio, with an estimated market value of $6.4M.

What does the chart on this GSK ownership page compare?

The chart compares TrueMark Investments, LLC's quarterly GSK portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did TrueMark Investments, LLC time their GSK position?

Based on 13F filing dates vs. subsequent GSK price moves, TrueMark Investments, LLC correctly timed 4 out of 4 reported position changes (100%). The annualised alpha on GSK relative to SPY over the holding period was +19.9%.

← Back to TrueMark Investments, LLC Holdings